Panel backs gene-editing for treating diseases
The potentially revolutionary gene-editing technologies should be used to treat diseases or disabilities, a panel of scientists suggested.
In its newly-issued report, the U.S. National Academy of Sciences said scientists should be allowed to use techniques like CRISPR-Cas9 for gene editing for treating certain deadly diseases.
The newly published report says, “There is some indication of public discomfort with using genome editing for what is deemed to be enhancement, whether for fear of exacerbating social inequities or of creating social pressure for people to use technologies they would not otherwise choose.”
Scientists in China last year launched a trial into using the CRISPR-Cas9 gene-editing technology to treat the deadly disease of lung cancer. The report noted that the United States’ ethical reservations may put the nation at a disadvantage.
While the panel did not recommend a total ban on use of gene-editing technologies to make inheritable changes to DNA, it stressed that the controversial technology should be tightly reserved for treatment or prevention of diseases. In other words, it should not be used for creating smarter, taller or more beautiful offspring.
Fashion major Michael Kors has agreed to acquire Jimmy Choo for $1.2 billion. New York-based Michael Kors will be able to diversify its portfolio by acquiring UK-based Jimmy Choo, a brand having strong sales in luxury segment.
Samsung is yet to officially unveil its next-generation flagship Galaxy Note 8 smartphone, but KGI Securities analyst Ming-Chi Kuo has already revealed some key details of the upcoming device’s dual camera setup.
Some employees of a tech firm in Wisconsin will soon be able to open doors, unlock office equipment, log into computers and even make in-house purchases with just a swipe of the hand.
The International Monetary Fund (IMF) has predicted US and UK economies will experience weaker-than-expected activity and expand more slowly this year than previously predicted.
The European Commission has confirmed that EU antitrust regulators are probing allegations of a cartel among a group of German carmakers, in an action that could result in bulky penalties for the companies.
Tesla Motors’ long-awaited Model 3 will be a “major test” for the Palo Alto-based electric car giant, according to industry analysts.